Eisler Capital (Uk) Ltd. Johnson & Johnson Call Options Transaction History

Eisler Capital (Uk) Ltd.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $1.91 Million - $2.2 Million	13,141 Added 5.2%	265,980 $43.1 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $7.65 Million - $8.36 Million	53,003 Added 26.52%	252,839 $37 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $12.6 Million - $13.2 Million	81,262 Added 68.53%	199,836 $31.6 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $8.94 Million - $9.76 Million	61,435 Added 107.52%	118,574 $18.6 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $8.28 Million - $9.27 Million	53,139 Added 1328.48%	57,139 $8.9 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $617,400 - $664,440	4,000 New	4,000 $662,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.